Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Verrill

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Breast Cancer Research : BCR|January 9, 2009
Introduction to sessions on 'Optimizing the implementation of future treatments--time to abandon traditional methods'Mark Verrill
European Journal of Cancer (Oxford, England : 1990)|May 26, 2009
Capecitabine and vinorelbine in metastatic breast cancerArlene Chan, Mark Verrill
BMJ (Clinical Research Ed.)|June 13, 2012
HER2 testing in patients with breast cancerJ Michael Dixon, Victoria Wilson, Mark Verrill, et al.
Future Oncology (London, England)|August 24, 2019
The rise of oncology biosimilars: from process to promiseMark Verrill, Paul Declerck, Sibylle Loibl, et al.
Breast Cancer Research and Treatment|October 14, 2006
Hormonal therapy for postmenopausal breast cancer: the science of sequencingWilliam R Miller, John M S Bartlett, Peter Canney, et al.
Health and Quality of Life Outcomes|July 16, 2005
An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancerJacqui Rodgers, Colin R Martin, Rachel C Morse, et al.
Sarcoma|June 4, 2008
A Guideline for the Management of Gastrointestinal Stromal Tumour (GIST)Ian Judson, Michael Leahy, Jeremy Whelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Desmoplastic small round-cell tumor of the pancreasAlbiruni Ryan, Abdul Razak, Janine Graham, et al.
BMJ (Clinical Research Ed.)|June 17, 2008
Unrecognised severe vitamin D deficiencyJohn L Sievenpiper, Elizabeth A McIntyre, Mark Verrill, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2016
Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancerNicola Cresti, Joanne Lee, Emma Rourke, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Breast Cancer Research : BCR|January 9, 2009
Introduction to sessions on 'Optimizing the implementation of future treatments--time to abandon traditional methods'Mark Verrill
European Journal of Cancer (Oxford, England : 1990)|May 26, 2009
Capecitabine and vinorelbine in metastatic breast cancerArlene Chan, Mark Verrill
BMJ (Clinical Research Ed.)|June 13, 2012
HER2 testing in patients with breast cancerJ Michael Dixon, Victoria Wilson, Mark Verrill, et al.
Future Oncology (London, England)|August 24, 2019
The rise of oncology biosimilars: from process to promiseMark Verrill, Paul Declerck, Sibylle Loibl, et al.
Breast Cancer Research and Treatment|October 14, 2006
Hormonal therapy for postmenopausal breast cancer: the science of sequencingWilliam R Miller, John M S Bartlett, Peter Canney, et al.
Health and Quality of Life Outcomes|July 16, 2005
An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancerJacqui Rodgers, Colin R Martin, Rachel C Morse, et al.
Sarcoma|June 4, 2008
A Guideline for the Management of Gastrointestinal Stromal Tumour (GIST)Ian Judson, Michael Leahy, Jeremy Whelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Desmoplastic small round-cell tumor of the pancreasAlbiruni Ryan, Abdul Razak, Janine Graham, et al.
BMJ (Clinical Research Ed.)|June 17, 2008
Unrecognised severe vitamin D deficiencyJohn L Sievenpiper, Elizabeth A McIntyre, Mark Verrill, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2016
Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancerNicola Cresti, Joanne Lee, Emma Rourke, et al.
Pageof 4